Immunotherapy: Checkpoint inhibitors, CAR-T cell therapy, and vaccine-based treatments.

Immunotherapy represents a paradigm shift in cancer treatment, harnessing the body’s immune system to combat tumors. Case studies featuring therapies like checkpoint inhibitors, CAR-T cells, and cancer vaccines demonstrate their transformative potential. For example, pembrolizumab’s success in treating metastatic melanoma has opened doors for its use in other cancers. These cases also highlight challenges, such as managing immune-related adverse events and identifying biomarkers to predict response. By documenting successes and obstacles, these studies provide a roadmap for refining immunotherapy and expanding its application to more cancer types, ultimately improving patient outcomes.